Skip to search formSkip to main contentSkip to account menu

omega-3 ethyl ester 90

Known as: P-OM3 adjunct 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The metabolic syndrome includes both dyslipidemia and impaired vascular function. Because extended-release niacin (ERN) and… 
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To evaluate the effects of prescription omega-3-acid ethyl esters on non-high-density lipoprotein cholesterol (HDL-C… 
2010
2010
Abstract Objective: Assess the long-term efficacy and safety of prescription omega-3-acid ethyl esters (P-OM3) coadministered… 
2009
2009
Abstract Background: Prescription omega-3-acid ethyl ester (P-OM3; Lovaza®) therapy is indicated for treating very high… 
2009
2009
Background/rationale: Treatment of severe hypertriglyceridemia is indicated to reduce the risk of pancreatitis in patients with… 
2009
2009
Preclinical and clinical studies demonstrate that the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid… 
Highly Cited
2008
Highly Cited
2008
Summary Omega-3 fatty acids (n-3 FA) from oily fish are clinically useful for lowering triglycerides and reducing risk of heart… 
Review
2007
Review
2007
ABSTRACT Background: A reliable means of treating hypertriglyceridemia is the use of large doses of the omega‑3 fatty acids… 
2006
2006
The coadministration of prescription omega‐3‐acid ethyl esters (P‐OM3) with a statin may present a treatment option for patients…